U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula C21H22BrFN4O3S
Molecular Weight 509.392
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MORPHOTHIADINE

SMILES

CCOC(=O)C1=C(CN2CCOCC2)NC(=NC1C3=CC=C(F)C=C3Br)C4=NC=CS4

InChI

InChIKey=SQGRDKSRFFUBBU-UHFFFAOYSA-N
InChI=1S/C21H22BrFN4O3S/c1-2-30-21(28)17-16(12-27-6-8-29-9-7-27)25-19(20-24-5-10-31-20)26-18(17)14-4-3-13(23)11-15(14)22/h3-5,10-11,18H,2,6-9,12H2,1H3,(H,25,26)

HIDE SMILES / InChI

Molecular Formula C21H22BrFN4O3S
Molecular Weight 509.392
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Substance Class Chemical
Created
by admin
on Wed Apr 02 09:12:59 GMT 2025
Edited
by admin
on Wed Apr 02 09:12:59 GMT 2025
Record UNII
R8MEF6D6PS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GLS-4
Preferred Name English
MORPHOTHIADINE
Common Name English
5-PYRIMIDINECARBOXYLIC ACID, 4-(2-BROMO-4-FLUOROPHENYL)-1,4-DIHYDRO-6-(4-MORPHOLINYLMETHYL)-2-(2-THIAZOLYL)-, ETHYL ESTER, (4R)-
Common Name English
Morphothiadine [WHO-DD]
Common Name English
GLS4
Code English
Code System Code Type Description
CAS
1793065-08-3
Created by admin on Wed Apr 02 09:12:59 GMT 2025 , Edited by admin on Wed Apr 02 09:12:59 GMT 2025
PRIMARY
PUBCHEM
25144422
Created by admin on Wed Apr 02 09:12:59 GMT 2025 , Edited by admin on Wed Apr 02 09:12:59 GMT 2025
PRIMARY PUBCHEM
FDA UNII
R8MEF6D6PS
Created by admin on Wed Apr 02 09:12:59 GMT 2025 , Edited by admin on Wed Apr 02 09:12:59 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
TARGET ORGANISM->INHIBITOR
inhibition of hepatitis B virus (HBV) capsid assembly
EC50
OFF-TARGET->INHIBITOR
IC50
METABOLIC ENZYME -> INDUCER
strong CYP3A4 induction in a concentration-dependent manner
MAY BE CLINICALLY SIGNIFICANT
Related Record Type Details
ACTIVE MOIETY